# Rivo Health reviews (2026): GLP-1 telehealth sellers | This GLP Four flat figures, all of them attributed to a seasonal sale that was still running out of season. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/rivo-health Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Four figures, all on a seasonal sale # Rivo Health review Four flat figures, all of them attributed to a seasonal sale that was still running out of season. ## The verdict Rivo Health publishes $149 a month for semaglutide and $199 for tirzepatide. Both orals carry the same figures. Coverage is 50 states. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Dose pricing Flat across doses States 50 Injection From $149/mo Oral From $149/mo Prescription Required Compounded Yes — not FDA-approved Availability 50 states Rivo Health sells both molecules as an injection and as an oral. Each molecule carries one price across both formats. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages describe plans rather than people. No clinician is named. The rate is stated flat, which answers the question most sellers dodge. The sale framing is the part to discount. 2. ## What happens when the dose goes up? The price is recorded as flat, so a dose increase should not move it. Nothing describes support at a step. 3. ## What the price includes Six months at $149 is $894 and at $199 is $1,194. Longer plans are said to save more without publishing what. The sale claims up to half off retail, and no retail figure is shown. 4. ## What it claims, and what it cites Both lines are compounded rather than manufactured. A pharmacy prepares them. The FDA does not review them before dispensing. ## Where it holds up, and where it does not - Strength: Flat across doses - Strength: Coverage in 50 states - Strength: Both formats carry a figure - Limitation: The rate is framed as a sale - Limitation: Multi-month savings are not published - Limitation: No retail figure backs the discount - Limitation: Nothing names the compounding pharmacy ## What the evidence says about this kind of treatment The assessment above is about Rivo Health. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants a flat rate and can ignore the seasonal framing. Wrong for A reader deciding on the strength of a discount nobody has quantified. ## The evidence behind what Rivo Health prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Rivo Health compares | Seller | Who it suits | Go | | --- | --- | --- | | Luci | Readers who take an asterisk seriously and plan to ask what it hides | | | Tru2u | Readers who want a flat rate and will ask what the combined product contains | | | TelePeptide | Readers who want the whole commitment ladder priced in advance | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Mevo Health](https://thisglp.com/reviews/mevo-health) [Midi Health](https://thisglp.com/reviews/midi-health) [Mint Med](https://thisglp.com/reviews/mint-med) [Mint Medical Clinic](https://thisglp.com/reviews/mint-medical) [Mochi Health](https://thisglp.com/reviews/mochi-health) [Mojoon](https://thisglp.com/reviews/mojoon) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is the sale price the real price? It is the only price on the page, months after the season it names. What do longer plans cost? The page says they save more. It does not say how much. Does the oral cost more? No. Each molecule carries one figure in both formats. Is Rivo Health legit? Rivo Health is a GLP-1 telehealth sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is Rivo Health expensive compared with other GLP-1 telehealth sellers? Rivo Health publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Rivo Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).